Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BCD-131 vs Mircera in Anemia of Chronic Kidney Disease on Dialysis
NCT07119372Phase 3Active, not recruiting
- Sponsor
- BIOCAD
- Start
- Mar 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated darbepoetin beta in anemia, sponsored by BIOCAD. Started Mar 2025; status: active, not recruiting.
02
Drugs
pegylated darbepoetin beta
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07119372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07119372.